Corvus Pharmaceuticals, Inc.(CRVS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CRVS Corvus Pharmaceuticals, Inc.

休市中 08-23 16:00:00 EDT

4.30

+0.15

+3.61%

盘后4.29

-0.01-0.23%

18:41 EDT

最高4.30	最低4.05	成交量23.13万
今开4.20	昨收4.15	日振幅6.11%
总市值2.69亿	流通市值1.63亿	总股本6,255万
成交额97.98万	换手率0.61%	流通股本3,787万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CRVS","market":"US","secType":"STK","nameCN":"Corvus Pharmaceuticals, Inc.","latestPrice":4.3,"timestamp":1724443200000,"preClose":4.15,"halted":0,"volume":231293,"hourTrading":{"tag":"盘后","latestPrice":4.29,"preClose":4.3,"latestTime":"18:41 EDT","volume":797,"amount":3434.26,"timestamp":1724452860962},"delay":0,"floatShares":37867425,"shares":62551281,"eps":-0.437465,"marketStatus":"休市中","marketStatusCode":7,"change":0.15,"latestTime":"08-23 16:00:00 EDT","open":4.2,"high":4.3,"low":4.0463,"amount":979810.9930104,"amplitude":0.061133,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.437465,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":0,"listingDate":1458705600000,"adjPreClose":4.15,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":4.23,"preClose":4.15,"latestTime":"09:09 EDT","volume":645,"amount":2728.3500000000004,"timestamp":1724418579327},"postHourTrading":{"tag":"盘后","latestPrice":4.29,"preClose":4.3,"latestTime":"18:41 EDT","volume":797,"amount":3434.26,"timestamp":1724452860962},"volumeRatio":0.5594124660277495,"impliedVol":1.0063,"impliedVolPercentile":0.254},"requestUrl":"/m/hq/s/CRVS","defaultTab":"news","newsList":[{"id":"2459942013","title":"Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.16%报3.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459942013","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459942013?lang=zh_cn&edition=full","pubTime":"2024-08-15 21:43","pubTimestamp":1723729401,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日21时43分，Corvus Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.16%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Cingulate Inc.、Nutriband Inc C/Wts 、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为3970.60%、1674.87%、363.58%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Cingulate Inc.、Cingulate Inc C/Wts 10/12/2026 ，振幅分别为103.98%、58.54%、50.00%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815214322a1d47145&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815214322a1d47145&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","CRVS"],"gpt_icon":0},{"id":"2459188774","title":"Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459188774","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459188774?lang=zh_cn&edition=full","pubTime":"2024-08-13 23:05","pubTimestamp":1723561542,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日23时05分，Corvus Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.03%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.80%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813230543942004a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813230543942004a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS","BK4139","BK4568"],"gpt_icon":0},{"id":"2458697882","title":"Corvus Pharmaceuticals, Inc.2024财年第二财季实现净利润-4.26百万美元，同比增加34.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458697882","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458697882?lang=zh_cn&edition=full","pubTime":"2024-08-12 00:16","pubTimestamp":1723393001,"startTime":"0","endTime":"0","summary":"8月12日，Corvus Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第二财季净利润为-4.26百万美元，同比增加34.46%；其中营业收入为0.00美元，每股基本收益为-0.07美元。机构评级：截至2024年8月12日，当前有4家机构对Corvus Pharmaceuticals, Inc.目标价做出预测，其中目标均价为7.88美元，其中最低目标价为3.50美元，最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120016479590466b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120016479590466b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS"],"gpt_icon":0},{"id":"2458992975","title":"Corvus Pharmaceuticals, Inc.盘中异动 股价大涨5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458992975","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458992975?lang=zh_cn&edition=full","pubTime":"2024-08-09 22:01","pubTimestamp":1723212090,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日22时01分，Corvus Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.57%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.21%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Adma Biologics Inc涨幅较大，Salarius Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.、Aditxt, Inc.较为活跃，换手率分别为47.43%、44.00%、14.12%，振幅较大的相关个股有Cingulate Inc.、An2 Therapeutics, Inc.、Brainstorm Cell Therapeutics Inc.，振幅分别为34.60%、22.48%、22.42%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809220130ab5d9374&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809220130ab5d9374&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","CRVS"],"gpt_icon":0},{"id":"2457896314","title":"Corvus Pharmaceuticals, Inc.盘中异动 早盘急速下挫5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457896314","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457896314?lang=zh_cn&edition=full","pubTime":"2024-08-08 21:42","pubTimestamp":1723124559,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日21时42分，Corvus Pharmaceuticals, Inc.股票出现波动，股价急速下挫5.02%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.99%。其相关个股中，Conduit Pharmaceuticals Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Oragenics Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Aditxt, Inc.较为活跃，换手率分别为224.89%、221.18%、69.91%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Oragenics Inc.、Entero Therapeutics Inc.，振幅分别为57.58%、40.44%、24.85%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。其他产品包括Ciforadenant 和Mupadolimab 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808214239af969f37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808214239af969f37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS","BK4139","BK4568"],"gpt_icon":0},{"id":"2457844346","title":"Corvus Pharmaceuticals, Inc.盘中异动 急速上涨8.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457844346","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457844346?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:31","pubTimestamp":1723037493,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日21时31分，Corvus Pharmaceuticals, Inc.股票出现异动，股价大幅拉升8.33%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，G1 Therapeutics, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Aditxt, Inc.涨幅较大，Scorpius Holdings, Inc.、Aditxt, Inc.、Silo Pharma, Inc.较为活跃，换手率分别为263.14%、140.69%、42.18%，振幅较大的相关个股有Aditxt, Inc.、Neurosense Therapeutics Ltd.、Enanta Pharmaceuticals, Inc.，振幅分别为16.93%、13.79%、11.92%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。其他产品包括Ciforadenant 和Mupadolimab 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072131339f17742c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072131339f17742c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS","BK4568","BK4139"],"gpt_icon":0},{"id":"2456299518","title":"Corvus Pharmaceuticals Inc    预计每股亏损 11 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456299518","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456299518?lang=zh_cn&edition=full","pubTime":"2024-08-03 10:01","pubTimestamp":1722650502,"startTime":"0","endTime":"0","summary":"   * Corvus Pharmaceuticals Inc    将于8月6日公布截至2024年6月30日的财报，预计季度营收将保持不变。*    * LSEG分析师对Corvus Pharmaceuticals Inc的平均预期是每股亏损11美分。* 华尔街对 Corvus Pharmaceuticals Inc 的 12 个月目标价中位数为 8.00 美元，高于其上一次收盘价 2.98 美元。8月3日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Corvus Pharmaceuticals Inc    预计每股亏损 11 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVS"],"gpt_icon":0},{"id":"2456237326","title":"Corvus Pharmaceuticals, Inc.盘中异动 股价大涨5.02%报3.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456237326","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456237326?lang=zh_cn&edition=full","pubTime":"2024-08-03 00:08","pubTimestamp":1722614888,"startTime":"0","endTime":"0","summary":"北京时间2024年08月03日00时08分，Corvus Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.02%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.52%。其相关个股中，Os Therapies Incorporated、Exicure, Inc.、Revelation Biosciences Inc C/Wts 10/01/2027 涨幅较大，Dermata Therapeutics, Inc.、Exicure, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为4936.06%、689.46%、99.72%，振幅较大的相关个股有Os Therapies Incorporated、Exicure, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为79.69%、64.24%、60.61%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240803000808aefcfced&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240803000808aefcfced&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","CRVS","BK4139"],"gpt_icon":0},{"id":"2456800074","title":"Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大涨6.61%报2.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456800074","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456800074?lang=zh_cn&edition=full","pubTime":"2024-08-01 21:30","pubTimestamp":1722519024,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日21时30分，Corvus Pharmaceuticals, Inc.股票出现波动，股价大幅拉升6.61%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。其相关个股中，Immuneering Corporation、Neurosense Therapeutics Ltd.、Precision Biosciences, Inc.涨幅较大，Immuneering Corporation、Cns Pharmaceuticals, Inc.、Neurosense Therapeutics Ltd.较为活跃，换手率分别为42.73%、36.45%、13.09%，振幅较大的相关个股有Neurosense Therapeutics Ltd.、Calidi Biotherapeutics, Inc.、Tnf Pharmaceuticals, Inc.，振幅分别为4.59%、2.55%、1.97%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801213025af9560a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801213025af9560a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVS","BK4568"],"gpt_icon":0},{"id":"2454532574","title":"Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454532574","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454532574?lang=zh_cn&edition=full","pubTime":"2024-07-26 22:22","pubTimestamp":1722003738,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日22时22分，Corvus Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.62%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Windtree Therapeutics, Inc.、Celularity Inc C/Wts 16/07/2026 、Sangamo Therapeutics, Inc.涨幅较大，Windtree Therapeutics, Inc.、Novabay Pharmaceuticals, Inc.、Cel-Sci Corporation较为活跃，换手率分别为4789.30%、149.11%、83.47%，振幅较大的相关个股有Windtree Therapeutics, Inc.、Sangamo Therapeutics, Inc.、Cel-Sci Corporation，振幅分别为81.16%、66.22%、63.13%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。其他产品包括Ciforadenant 和Mupadolimab 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726222218af945b00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726222218af945b00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS","BK4568","BK4139"],"gpt_icon":0},{"id":"2454386508","title":"Corvus Pharmaceuticals, Inc.盘中异动 股价大涨5.53%报2.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454386508","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454386508?lang=zh_cn&edition=full","pubTime":"2024-07-26 03:21","pubTimestamp":1721935273,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日03时21分，Corvus Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.53%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.82%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.涨幅较大，Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.、Azitra Inc较为活跃，换手率分别为5068.44%、597.76%、338.81%，振幅较大的相关个股有Psyence Biomedical Ltd.、Exicure, Inc.、Salarius Pharmaceuticals, Inc.，振幅分别为158.05%、140.39%、98.60%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726032113aefb7b92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726032113aefb7b92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS","BK4139","BK4568"],"gpt_icon":0},{"id":"2453059025","title":"Corvus Pharmaceuticals, Inc.盘中异动 急速拉升5.09%报2.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453059025","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453059025?lang=zh_cn&edition=full","pubTime":"2024-07-23 23:14","pubTimestamp":1721747677,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日23时14分，Corvus Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.09%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Azitra Inc、Salarius Pharmaceuticals, Inc.、Adial Pharmaceuticals, Inc涨幅较大，Salarius Pharmaceuticals, Inc.、Azitra Inc、Adial Pharmaceuticals, Inc较为活跃，换手率分别为5402.21%、4849.34%、3300.59%，振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、Azitra Inc、Adial Pharmaceuticals, Inc，振幅分别为366.13%、365.43%、137.74%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407232314379681f5ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407232314379681f5ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","CRVS"],"gpt_icon":0},{"id":"2452219163","title":"Corvus Pharmaceuticals, Inc.盘中异动 大幅跳水5.15%报2.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452219163","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452219163?lang=zh_cn&edition=full","pubTime":"2024-07-17 22:45","pubTimestamp":1721227541,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日22时45分，Corvus Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.15%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.63%。其相关个股中，Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Aditxt, Inc.涨幅较大，Aptevo Therapeutics Inc.、Aditxt, Inc.、Longeveron Inc.较为活跃，换手率分别为2582.42%、1217.85%、262.41%，振幅较大的相关个股有Aptevo Therapeutics Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Aditxt, Inc.，振幅分别为76.39%、43.75%、31.25%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717224541aefa27d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717224541aefa27d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS","BK4568","BK4139"],"gpt_icon":0},{"id":"2451990101","title":"Corvus Pharmaceuticals, Inc.盘中异动 快速拉升5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451990101","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451990101?lang=zh_cn&edition=full","pubTime":"2024-07-16 21:50","pubTimestamp":1721137810,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日21时50分，Corvus Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.50%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，Silo Pharma, Inc.、Scisparc Ltd.、Conduit Pharmaceuticals Inc.涨幅较大，Silo Pharma, Inc.、Scisparc Ltd.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为1641.94%、857.07%、90.35%，振幅较大的相关个股有Scisparc Ltd.、Aeon Biopharma, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为40.48%、36.40%、36.00%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。其他产品包括Ciforadenant 和Mupadolimab 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716215010941f7712&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716215010941f7712&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS","BK4139","BK4568"],"gpt_icon":0},{"id":"2448165777","title":"Corvus Pharmaceuticals, Inc.盘中异动 快速跳水5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448165777","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448165777?lang=zh_cn&edition=full","pubTime":"2024-07-02 23:15","pubTimestamp":1719933344,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日23时15分，Corvus Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.41%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.20%。其相关个股中，Zura Bio Limited C/Wts 、Nls Pharmaceutics Ltd.、Mustang Bio, Inc.涨幅较大，Mustang Bio, Inc.、Gri Bio, Inc.、Geovax Labs, Inc.较为活跃，换手率分别为48.93%、45.73%、35.66%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Anew Medical Inc C/Wts 21/06/2029 、Revelation Biosciences Inc C/Wts 10/01/2027 ，振幅分别为72.83%、39.76%、39.50%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702231545941f3290&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702231545941f3290&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","CRVS"],"gpt_icon":0},{"id":"2446155850","title":"Corvus Pharmaceuticals, Inc.股价飙升11.73% 市值涨1467.46万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446155850","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446155850?lang=zh_cn&edition=full","pubTime":"2024-06-27 21:32","pubTimestamp":1719495123,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日21时32分，Corvus Pharmaceuticals, Inc.股票出现异动，股价大幅上涨11.73%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Nls Pharmaceutics Ltd.、Effector Therapeutics Inc C/Wts 31/12/2025 、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Nls Pharmaceutics Ltd.、Gri Bio, Inc.、Kala Bio, Inc.较为活跃，换手率分别为147.56%、90.39%、58.07%，振幅较大的相关个股有Nls Pharmaceutics Ltd.、冠科美博、Engene Holdings Inc.，振幅分别为19.33%、12.57%、10.75%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062721320395de72e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062721320395de72e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","CRVS"],"gpt_icon":0},{"id":"2445074986","title":"Corvus Pharmaceuticals, Inc.盘中异动 股价大涨5.34%报1.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445074986","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445074986?lang=zh_cn&edition=full","pubTime":"2024-06-24 21:32","pubTimestamp":1719235932,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日21时32分，Corvus Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.34%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，Revelation Biosciences, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、阿里拉姆制药涨幅较大，Revelation Biosciences, Inc.、Gri Bio, Inc.、Effector Therapeutics, Inc.较为活跃，换手率分别为343.52%、43.78%、33.50%，振幅较大的相关个股有Revelation Biosciences, Inc.、Psyence Biomedical Ltd.、Geovax Labs, Inc.，振幅分别为23.70%、11.62%、10.73%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624213212968163cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624213212968163cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","CRVS"],"gpt_icon":0},{"id":"2445794102","title":"Corvus Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445794102","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445794102?lang=zh_cn&edition=full","pubTime":"2024-06-22 03:58","pubTimestamp":1718999937,"startTime":"0","endTime":"0","summary":"北京时间2024年06月22日03时58分，Corvus Pharmaceuticals, Inc.股票出现波动，股价急速下挫5.76%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062203585896815d7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062203585896815d7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","CRVS","BK4139"],"gpt_icon":0},{"id":"2444167032","title":"Corvus Pharmaceuticals, Inc.盘中异动 早盘急速下挫5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444167032","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444167032?lang=zh_cn&edition=full","pubTime":"2024-06-17 21:39","pubTimestamp":1718631544,"startTime":"0","endTime":"0","summary":"北京时间2024年06月17日21时39分，Corvus Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.39%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。其相关个股中，Mustang Bio, Inc.、Scinai Immunotherapeutics Ltd、Cns Pharmaceuticals, Inc.涨幅较大，Scinai Immunotherapeutics Ltd、Mustang Bio, Inc.、Longeveron Inc.较为活跃，换手率分别为2777.91%、501.57%、81.34%，振幅较大的相关个股有Mustang Bio, Inc.、Scinai Immunotherapeutics Ltd、Cns Pharmaceuticals, Inc.，振幅分别为48.77%、27.79%、20.02%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061721390496814a0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061721390496814a0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVS","BK4568"],"gpt_icon":0},{"id":"2443260483","title":"Corvus Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.66%报2.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443260483","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2443260483?lang=zh_cn&edition=full","pubTime":"2024-06-15 03:05","pubTimestamp":1718391956,"startTime":"0","endTime":"0","summary":"北京时间2024年06月15日03时05分，Corvus Pharmaceuticals, Inc.股票出现波动，股价大幅跳水5.66%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。其相关个股中，Effector Therapeutics Inc C/Wts 31/12/2025 、Nkgen Biotech Inc C/Wts 31/05/2028、Tracon Pharmaceuticals, Inc.涨幅较大，Cns Pharmaceuticals, Inc.、Longeveron Inc.、Bio-Path Holdings, Inc.较为活跃，换手率分别为2364.28%、1431.54%、268.17%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Estrella Immunopharma Inc C/Wts 29/09/2028，振幅分别为129.28%、67.98%、60.25%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615030557968145d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615030557968145d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","CRVS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.corvusbiotech.com","stockEarnings":[{"period":"1week","weight":0.0488},{"period":"1month","weight":0.9816},{"period":"3month","weight":1.0874},{"period":"6month","weight":0.8298},{"period":"1year","weight":1.0525},{"period":"ytd","weight":1.4432}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Corvus Pharmaceuticals, Inc.于2014年1月27日在特拉华州注册成立,并于2014年11月开始运作。该公司是一家临床阶段的生物制药公司，专注于发展和商业化那些旨在利用免疫系统攻击癌细胞的新免疫治疗肿瘤方案。自从2014年11月开始运营起，已建成四个免疫肿瘤的方案，其中三个重点腺苷癌症轴调节免疫反应的管道。该公司的主导候选产品，CPI-444，A2A受体腺苷，免疫检查点的口服小分子拮抗剂。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.025631},{"month":2,"riseRate":0.375,"avgChangeRate":-0.030453},{"month":3,"riseRate":0.375,"avgChangeRate":0.01862},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.096588},{"month":5,"riseRate":0.666667,"avgChangeRate":0.319834},{"month":6,"riseRate":0.222222,"avgChangeRate":-0.075817},{"month":7,"riseRate":0.444444,"avgChangeRate":0.055809},{"month":8,"riseRate":0.666667,"avgChangeRate":0.113614},{"month":9,"riseRate":0.375,"avgChangeRate":0.074838},{"month":10,"riseRate":0.25,"avgChangeRate":-0.073609},{"month":11,"riseRate":0.5,"avgChangeRate":-0.015675},{"month":12,"riseRate":0.25,"avgChangeRate":-0.011327}],"exchange":"NASDAQ","name":"Corvus Pharmaceuticals, Inc.","nameEN":"Corvus Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Corvus Pharmaceuticals, Inc.(CRVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Corvus Pharmaceuticals, Inc.(CRVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Corvus Pharmaceuticals, Inc.,CRVS,Corvus Pharmaceuticals, Inc.股票,Corvus Pharmaceuticals, Inc.股票老虎,Corvus Pharmaceuticals, Inc.股票老虎国际,Corvus Pharmaceuticals, Inc.行情,Corvus Pharmaceuticals, Inc.股票行情,Corvus Pharmaceuticals, Inc.股价,Corvus Pharmaceuticals, Inc.股市,Corvus Pharmaceuticals, Inc.股票价格,Corvus Pharmaceuticals, Inc.股票交易,Corvus Pharmaceuticals, Inc.股票购买,Corvus Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Corvus Pharmaceuticals, Inc.(CRVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Corvus Pharmaceuticals, Inc.(CRVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}